The International Online Journal of Cancer & Therapeutics is a peer-reviewed open acess journal that publishes original research articles as well as review articles in all areas of Oncology. this practical journal also includes information on new products, new therapies and patient management, as well as reviews of the latest research. Cancer is a complex problem. The international effort to understand and control it involves clinicians trained in many branches of medicine and scientists from most biological disciplines, chemistry, pharmaceutical and physical sciences The International Online Journal of Cancer & Therapeutics exists to serve the needs of this diverse community, providing a forum for prompt communication of original and innovative research findings that have relevance to understanding the etiology of cancer and to improving the treatment and survival of patients.

The journal publishes important original studies, reviews, and perspectives within the major topic areas of biology of premalignancy, risk factors and risk assessment, early detection research, immunoprevention, and chemopreventive and other interventions, including the basic science behind them. This journal comprises preclinical, clinical and translational research, with special attention given to molecular discoveries and an emphasis on building a translational bridge between the basic and clinical sciences. Main focuses of interest include: systemic anticancer therapy (with specific interest on molecular targeted agents and new immune therapies), randomized trials (including negatives ones), top-level guidelines, and new fields currently emerging as key components of personalized medicine, such as molecular pathology, bioinformatics, modern statistics, and biotechnologies. Radiotherapy, surgery and pediatrics manuscripts can be considered if they display a clear interaction with one of the fields above or are paradigm-shifting.

Oncology is the diagnosis and treatment of cancers,including breast,prostate,colon,lung and ovarian cancers as well as brain tumors,leukemia,lymphoma and many other types of cancer.. A doctor who works in the field of oncology is called an oncologist. The primary regions of oncology are radiation, which is worried with radiation treatment, or radiotherapy; surgical, which is contained specialists who spend significant time in tumor evacuation; therapeutic, which manages disease drugs, including chemotherapy; and interventional, which includes interventional radiologists who have some expertise in insignificantly obtrusive picture guided tumor treatment.


committee

Members

ThumbnailImage

Mohammed Abd El-Dayem Sallam

Professor

*    B. Sc. (Hons), Chemistry, Faculty of Science, Alexandria University, June 1963.

*    M. Sc. Chemistry, Faculty of Science, Alexandria University, February 1967.

*    Ph. D. Chemistry, Faculty of Science, Alexandria University, June 1970.

 

*    Synthesis of Heterocyclic Derivatives from Carbohydrates,

*    Synthesis of C-Nucleoside Analogs of Biological Interest,

*    Synthesis of Anthracycline Antibiotics.

*    Optical Rotatory Dispersion and Circular Dichroism.

*    Synthesis of Labeled Carbohydrae Derivatives 14C, 13C, 2H, 3H.

*    Studies on Polysaccharides.

*    Natural Products.

*    NMR Spectroscopy and conformational analysis.

  • Alexandria University Scientific Research Award in Chemistry at 1980.
  • Member , Editorial Board, Journal of Carbohydrate Chemistry, June 1981-2000.
  • Editorial Board  Member ,Green and sustainable Chemistry , GSC;  July  2011-   present.
  • Editorial Board Member , Vitamins and Minerals ReportsHerbert Publications,  Novemver 13, 2013
  • Editorial Board Member , Journal of Family Practice” HOAJ, Herbert Publications , March 2014- Present
  • Editorial board member, Trends in Green Chemistry June 17, 2015- Present
  • Fullbright Receipt 1996 .